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ABSTRACT 
 
OBJECTIVES 
To analyse the effect of upper limb exercises along with treadmill training on heart rate 
and spo2 among copd subjects. 
STUDY DESIGN 
Pre test and post test experimental study. 
METHODOLOGY 
Subjects were assigned into two groups with 15 in GROUP A and 15 in GROUP B. The 
GROUP A subjects underwent for conventional therapy such as diaphragmatic breathing 
exercise and chest mobility exercise, while GROUP B underwent upper limb exercises 
and treadmill training along with conventional therapy. 
Treadmill training is for 10 minutes daily, lasted for 8 weeks. 
OUTCOME MEASURES 
Heart rate and SPO2 were measured by using pulsoximeter. 
RESULTS 
The data were analysed using independent and paired t test at 5%level of significance. 
There was significant difference between the groups in all the outcome measures. There 
was significant improvement on heart rate and SPO2 in both groups, but the mean shows 
that GROUP B has more improvement than GROUP A. 
CONCLUSION 
The study reveal that there is significant improvement in heart rate and spo2 on subject 
who underwent upper limb exercises along with treadmill training. 
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CHAPTER I 
     1.1 INTRODUCTION 
The common disease entity of chronic bronchitis and emphysema is known as 
Chronic Obstructive Pulmonary Disease.  COPD is defined as a disease state 
characterized by airflow limitation that is not fully reversible. The airflow limitation is 
usually both progressive and associated with an abnormal inflammatory response of the 
lungs to noxious particle or gases GOLD, 2001. COPD is characterized by reduced 
maximum expiratory flow and slow forced emptying of lungs which is slowly 
progressive and mostly irreversible to present medical treatment ERS, 1995. The 
impairment of lung function is largely fixed but is partially reversible by bronchodilator 
or other therapy BTS,1997.COPD is largely preventable Huib,1999. 
Chronic Obstructive Pulmonary Disease (COPD) is a major cause of chronic 
morbidity and mortality throughout the world. For patients with COPD, degradation in 
lung function is progressive, leading to premature disability and death. As the lung 
function decreases, the ability to engage in activities of daily living decreases, and thus 
the quality of life is impaired.  
The prevalence of COPD reported in different population studies from India is 
highly variable. The prevalence rates in male subjects of 2.12% studies reported from 
North are generally higher that 1.4% to 4.08% reported from south, respective range for 
female subjects vary from 1.3% to 4.9% from north and from 2.55% to south India, 
(Indian Journal of Chest Diseases And Allied Sciences,2004). The prevalence of COPD 
among all patients at Medical College Hospital, Trivandrum from January 2000 to  
December 2000 was found to be 30.23% with percentage of  male patients 85.27 and of 
females 13.7 Sofia Salim et al., 2002. 
            It has been recognized that chronic obstructive pulmonary disease (COPD) is a 
systemic disease which has been shown to negatively affect the cardiovascular and 
autonomic nerve system.van Gestel AJR, Steier J. Autonomic dysfunction in patients 
with chronic obstructive pulmonary disease. 
 The autonomic nervous system (ANS) regulates multiple physiological processes. 
Amongst other factors it is responsible adjusting heart rate, blood pressure, 
gastrointestinal secretion, temperature regulation, vagally mediated reflex constriction of 
airway smooth muscle, secretion from sub mucosal glands, capillary permeability and 
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blood flow in the bronchial circulation, cardiovascular responses to exercise and release 
of mediators from the mast cells and other inflammatory cells. Dysfunctions of the 
autonomic nervous system are recognized by the symptoms that result from failure of the 
sympathetic or parasympathetic components. Disruption of autonomic reflexes with 
increased sympathetic tone, loss of parasympathetic tone and altered baroreceptor 
sensitivity (BRS) have been shown to be major risk factors for cardiac morbidity and 
mortality. 
Chronic obstructive pulmonary disease (COPD) is associated with abnormal 
inflammatory response of the lungs to chronic inhalational of noxious inhaled gases or 
particles causing obstruction of the airways which is often irreversible. There is 
increasing evidence, indicating that COPD is more complex and not only involving 
airflow obstruction. It has been recognized that COPD is a systemic disease which has 
been shown to negatively affect the cardiovascular and autonomic nerve system 
The upper extremities play an important role in many activities of daily living 
such as bathing, dressing, hanging out the wash, and gardening. Patients with COPD 
frequently experience marked dyspnea and fatigue when performing these simple tasks. 
Upper limb activities commonly require unsupported arm exercise, which poses a unique 
challenge for patients with COPD, whose upper limb muscles are required to act as 
accessory muscles of respiration The  effectiveness of lower limb (LL) exercise training 
for patients with COPD has been well documented, with consistent and clinically 
significant improvements in exercise capacity, symptoms, and quality of life. 
The benefits of combined upper limb and lower limb training, however, are less 
well defined. Therefore, there exists a need to measure the exercise performance and the 
functional outcome by combining unsupported upper limb exercises with lower limb 
exercises. 
 COPD is a major cause of morbidity, mortality and health care costs. Exercise 
intolerance is one of the most troublesome manifestations of COPD. Patients in initial 
stages of the disease may experience dyspnoea during heavy exertion that is attributed to 
"slowing down with age." Patients with moderate and severe COPD commonly have 
difficulty performing normal daily tasks such as work, recreational exercise, hobbies, 
and self-care. Dyspnoea, leg fatigue, and discomfort are the main symptoms that limit 
exercise. The resultant inactivity leads to a progressive deterioration that further increase 
the respiratory effort related to any given task. Ultimately, patients often become 
progressively homebound and isolated, and may develop worsening depression and 
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anxiety. Such depression is associated with significant disturbances in physical function. 
Indeed, exercise capacity and healthstatus also correlate inversely with morbidity. 
The management of COPD has advanced significantly over the past few years. In 
particular, pulmonary rehabilitation has gradually been accepted as the gold standard of 
care for patients with COPD. Recent evidence-based guidelines (12) have considered 
exercise training a necessary and critically important part of pulmonary rehabilitation if 
desired results are to be achieved. Over the recent years, researchers and clinicians have 
increasingly recognised the role of skeletal muscle dysfunction as an indicator of 
advanced stages of COPD. The physical exercise component has therefore become a 
mainstay of respiratory rehabilitation. Several studies have shown that physical exercise 
can reverse COPD induced skeletal muscle dysfunction as well as the morphological and 
metabolic changes of skeletal muscles. There is; however, substantial variation in 
exercise protocols used in clinical trials. This variation feeds an ongoing debate on the 
optimal exercise protocol and on how the general impact of modifying principles, 
training. Intensity, specificity, and reversibility known from healthy subjects can be 
applied to COPD patients. 
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1.2 NEED FOR THE STUDY 
 It has been recognized that chronic obstructive pulmonary disease (COPD) is a 
systemic disease which has been shown to negatively affect the cardiovascular and 
autonomic nerve system. In COPD patients the activity of sympathetic nerves may be 
affected by recurrent hypoxemia, hypercapnia, increased intrathoracic pressure swings 
due to airway obstruction, increased respiratory effort, systemic inflammation and the 
use of betasympathomimetics. Furthermore, experimental findings suggest that 
autonomic dysfunction characterized by a predominance of sympathetic activity can 
significantly modulate further inflammatory reactions. 
Effective positioning, relaxed breathing techniques, postural drainage, technique 
to aid secretions are the recognized treatment intervention for these patients. Respiratory 
muscle stretching is not that much  relevant  during these treatment programme . So 
interventions to improve efficiency of respiratory muscles  is important in the 
rehabilitation of COPD patients. 
COPD is a condition which has a wide variety of treatment program such as 
exercises, treadmill, breathing ex. Usually these treatment programs gives less important 
to autonomic nervous system. So in this study the researcher is trying to find out the 
efficacy of Upper Limb  Exercise and 10 minutes Treadmill Training on 
Improving Autonomic Nervous control in patients with COPD . 
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1.3 AIM AND OBJECTIVES OF STUDY 
 
 AIM OF THE STUDY 
To find out the Efficacy of Upper Limb exercise and 10 minutes Treadmill 
Training to improve Autonomic Nervous control in patients with COPD. 
OBJECTIVES OF THE STUDY 
• To find out the effectiveness of conventional therapy for treatment of COPD. 
• To find out the effectiveness of conventional therapy with Upper Limb exercises                                
and 10 minutes Treadmill training on Improving Autonomic Nervous control in 
patients with COPD .  
• To compare the effectiveness of both Upper Limb exercises and 10 minutes 
Treadmill Exercise and conventional treatment on Improving Autonomic 
Nervous control in patients with COPD . 
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1.4 HYPOTHESIS 
Null Hypothesis– There is no significant improvement Autonomic Nervous control in 
COPD patients with Upper limb exercises and 10 minutes Treadmill Training. 
Alternate Hypothesis- There is significant improvement Autonomic Nervous control in 
COPD patients with Upper Limb exercises and 10 minutes Treadmill Training. 
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1.5 OPERATIONAL DEFINITION 
COPD- chronic obstructive pulmonary disease is comprised primarily of three related 
conditions- chronic bronchitis, chronic asthma, and emphysema. In  each condition there 
is chronic obstruction of the flow of air through the airways and out of the lungs, and the 
obstruction generally is permanent and may be progressive over time. 
 Faling J 
Autonomic Nervous Control- ANS is the part of peripheral nervous system that 
acts as a control system functioning largely below the level of consciousness and 
controls visceral functions.  Stewart marsh  
Treadmill- a treadmill is an exercise machine for running or walking while staying in 
one place.                                                                                                 
 Costello V 
Upper Limb Exercise-Exercise that is design  to strenghten upper limb muscles.  
 Farlex 
Heart Rate-Number of heart rate per unit of time usually expressed as beats 
per minute. 
 Hougston misslin  
SPO2-Oxgyen saturation refers to the amount of oxygen carried in red blood 
cells. 
 Leigh.a.zaykoski 
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CHAPTER II 
REVIEW OF LITERATURE 
American Thoracic Society,(2008)defined chronic obstructive pulmonary 
disease [COPD] is a preventable and treatable disease state characterized by airflow 
limitation that is not fully reversible. The airflow limitation is usually progressive and is 
associated with an abnormal inflammatory response of lungs to noxious particles or 
gases, primarily caused by cigarette smoking. Although COPD affects lungs, it also 
produces significant systemic consequences.  
WHO, (2008) defined COPD as a disease state characterized by airflow 
limitation that is not fully reversible. The airflow limitation is usually both progressive 
and associated with an abnormal inflammatory response of the lung to noxious particles 
or gases. 
Satsharma et al., (2007) defined COPD as a disease state characterized by the 
presence of airflow obstruction due to chronic bronchitis or emphysema. The airflow 
obstruction generally is progressive, may be accompanied by airway hyper reactivity and 
may be partially reversible. 
Satsharmaet al., (2007)reported that the primary cause of COPD is exposure to 
tobacco smoke. Clinically significant COPD develops in15 % of cigarette smokers. Age 
of initiation of smoking, total pack-years, and current smoking status predict COPD 
mortality. Airway hyper responsiveness stipulates that patient who has non-specific 
airway hyper reactivity and who smoke are at increased risk of developing COPD with 
an accelerated decline in lung function. 
Henke O.M et al.,(2006) commended that the anatomic disruption, ciliary 
impairment, plasma exudation and fibrin can change the viscoelasticity of the mucus and 
impair the surfactant properties of the airway lining material cause small airway 
obstruction and gas trapping. These changes in mucus clearance lead to ventilation-
perfusion mismatch, impaired gas exchange, pulmonary hyperinflation, and inspiratory 
loading of the respiratory muscles leading to fatigue and ineffective cough. 
VanGestel AJR, SteierJIt(2006) has been recognized that chronic obstructive 
pulmonary disease (COPD) is a systemic disease which has been shown to negatively 
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affect the cardiovascular and autonomic nerve system. The complexity of the physiologic 
basis by which autonomic dysfunction occurs in patients with COPD. 
Stein PK, Nelson P(2006) It has been recognized that COPD is a systemic 
disease which has been shown to negatively affect the cardiovascular and autonomic 
nerve system 
Volterrani M, Scalvini S, Mazzuero G(2006) Patients with COPD have 
functional alterations of cardiac autonomic modulation as reflected in elevated resting 
heart rate, reduced baroreflex sensitivity, reduced heart rate variability (HRV) 
Eckhart and colleagues(2005) found evidence that the respiratory pattern 
influences autonomic output by inhibiting the ability of baroreceptor inputs to modulate 
the activity of autonomic motoneurons. The influence of the respiratory pattern on 
cardiac autonomic modulation is well known: the magnitude of parasympathetic induced 
heart rate variability has been shown to depend on both the lung hyperinflation (tidal 
volume VT) and respiratory rate (FR) 
Hough A, (2005)stated that a common disease entity of chronic bronchitis and 
emphysema is known as chronic obstructive pulmonary disease. COPD is a slowly 
progressive disease and most airways obstruction is fixed, although some reversibility 
may be demonstrated with medication 
Fabbri L.M et al., (2005)conducted a study and that showed the prevalence of 
COPD determined by criteria of GOLD was 17.2 % among subjects older than 45 year. 
Prevalence increased with increasing age, especially in males, in those with more than 20 
pack, years of smoking, and in low-income subjects. 
Aggarwal A.N. et al., (2004) stated that the prevalence of COPD reported in 
different population studies from India is highly variable. The prevalence rates in male 
subjects of 2.12%studies reported from North are generally higher that 1.4% to 4.08% 
reported from South, respective range for female subjects vary from 1.3% to 4.9 % from 
North and from 2.55% to South India. 
           Agustı´ AGN, Cotes J, Wagner PD (2004) cardiac output appears to increase 
normally during exercise, even in severe COPD 
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          Raupach T, Bahr F(2004) It may be postulated, that the development of a rapid 
shallow breathing pattern during an exacerbation or exercise probably is a contributor to 
autonomic dysfunction in patients with COPD. 
          Stewart,Marsh(2003) Cardiovascular autonomic nerve function, arterial oxygen 
and carbon dioxide tensions, lung function and cigarette consumption were also 
recorded. The acetylcholine sweat-spot test was highly repeatable in eight COPD 
patients, no person with normal or frankly abnormal function being wrongly assigned. 
         Starr J. A,(2001) stated that in COPD chronic inflammation from inhaling 
pollutants causes hypertrophy of glands and goblet cells results in excessive mucus 
production, which either partially or completely obstruct the airway. Decrease in ciliary 
function also impair airway clearance and contribute to airway obstruction. When 
excessive secretions are present in an airway, air can be inspired around the secretion. 
During exhalation only small amount of air escapes before the airway close down around 
the secretion, trapping air distal to the mucus accounts for hyperinflation. 
Allen M.B et al., (2001)stated that the patient with COPD will have impairment of 
expiratory flow , best measured by spirometry. Blood gases should be performed to 
identify the severity of hypoxemia and decide if oxygen therapy is required. Chest X -ray 
is important, not for confirming the diagnosis of COPD but to exclude the other reasons 
for the presentation. 
Bernardi L(1999) Autonomic abnormalities have consistently been found in COPD. 
These span from a reduction in the heart rate variability, a reduction in the respiratory 
sinus arrhythmia and a reduction in the baroreflex sensitivity, together with a direct 
increase in the muscle sympathetic nerve activity. 
Arch physical med rehabilitation(1999) .The findings demonstrate that a treadmill 
exercise program based on stress test data can increase the efficiency and thus exercise 
tolerance of persons with COPD. 
Marcelo Fernandez(1997) did study in efficiency of diaphragmatic breathing exercise 
in patients with COPD.Diaphgramatic breathing exercise can improve breathing pattern 
and ventilatory efficiency. 
Thomson A, (1995) commended that COPD is more common in middle to late adult life 
and in men more than women (ratio 5:1) .It is more common in urban areas than in rural 
areas 
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CHAPTER III 
MATERIALS AND METHODOLOGY 
3.1 MATERIALS  
• Data collection sheet   
• Consent form                
• Stethoscope 
• Pillow 
• Chair 
• Table 
• Treadmill  
• Pulsoximeter 
  3.2 METHODOLOGY 
3.2.1 Study Design  
Quasi Experimental Study, Design with pretest and posttest 
evaluation of both in experimental and control group. 
3.2.2 Sampling Design 
 Purposive random sampling technique 
3.2.3 Population 
The sample consists of 30 subjects with COPD were selected and 
assigned into two  groups. 
Control Group 
It consist of 15 COPD patients treated with diaphragmatic breathing 
exercise and chest mobility (conventional treatment). 
Experimental group 
It consists of 15 COPD subjects treated with Upper Limb Exercise 
and 10 minutes Treadmill training along with conventional therapy. 
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3.2.4 Sample 
      30 subjects 
3.2.5 Selection criteria 
3.2.5.1 Inclusions Criteria 
• Patients with mild to moderate COPD 
• Age 45 – 60  
• Males  
3.2.5.2 Exclusion Criteria 
• Malignancy 
• Lung surgeries 
• Cardiac Surgeries 
• Neurological problems 
• Mental retardation 
• Recent fractures to ribs 
• Visual and auditory problem 
• Non cooperative patient 
3.2.6 Study setting 
Ashwini multi-speciality hospital ,Coimbatore. 
  Kovai respiratory care centre, Coimbatore. 
3.2.7 Study duration 
  
13 
6 months 
3.2.8 Treatment duration 
8 weeks 
3.2.9 Parameter 
Pulsoximeter 
3.2.10 Outcome measure 
Heart rate, SPO2 
3.2.11 Study procedure 
                Written consent was being obtained from the patient.  Each patient 
will undergo formal evaluation of inclusion in to the study. Before starting 
the treatment the complete procedure was explained to the patients. 
Thirty subjects who are satisfied with inclusion criteria are randomly 
allocated to GROUP A or GROUP B. Pre-test assessment is taken before 
going to training programme. Training programme for GROUP B consisted 
of upper limb exercises and 10 minutes of treadmill exercise along with 
conventional therapy.  For the GROUP A subjects, diaphragmatic exercise 
and chest mobility are given. 
Post-test assessment is taken at the end of 8 weeks. 
3.2.12 Statistical tool 
 Pre test and Post test values of the study will be collected and 
assessed for variation in the improvement and their results will be analyzed 
using Independent ‘ t’ test and Paired ‘t’ test. 
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INDEPENDENT `t’ TEST (between groups) 
 
 
        Where,                         
 
  
  PAIRED `t’ TEST (within groups)  
                                 t =  Where, 
                      S =  
 
 S=combined standard deviation 
 =difference between initial & final readings in group A & group B   respectively. 
& =number of patients in group A & group B respectively. 
 =Mean of group A & group B respectively. 
Level of significance: 5%. 
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3.2.13 Treatment Technique  
Thirty subjects who are satisfied with inclusion criteria are randomly allocated to 
GROUP A or GROUP B. Pre-test assessment is taken before going to training 
programme.   
 
Training programme for GROUP B consisted of upper limb exercises and 10 
minutes of treadmill exercise along with conventional therapy . The exercises are the 
following: 
 
A, Throwing a ball against the wall with arms above horizontal in sitting position. 
B, Passing a bean bag over the head in sitting position. 
C, Exercise on over head pulleys in sitting. 
D, Moving  ring across a wire without touching a wire while arm was above horizontal. 
Duration -40 seconds following 20 second rest for each exercise for 4 times in 4 minute. 
             For the GROUP A subjects, diaphragmatic exercise and chest mobility exercise 
are given. The subject is asked to place his both palms just below the ribcage. The 
subject is instructed to inhale through the mouth during which his abdomen moves 
forward and then exhale through the mouth. The subject should do this exercise on a 
regular basis for 10 minutes.  
Post-test assessment is taken at the end of 8 weeks             
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CHAPTER IV 
DATA PRESENTATION 
 
TABLE –I 
CONTROL GROUP (GROUP - A) 
 
HEART RATE SPO2 
S.NO 
Pre test Post test Pretest Post test 
1 80 78 89 91 
2 90 88 90 91 
3 95 94 88 90 
4 99 97 88 89 
5 89 88 91 91 
6 95 93 90 92 
7 100 98 90 91 
8 99 97 92 93 
9 97 95 89 92 
10 83 81 89 93 
11 91 91 90 92 
12 89 88 91 92 
13 92 91 88             91 
14 91 90 87 90 
15 89 88 89 97 
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TABLE –II 
 
 
EXPERIMENTAL GROUP (GROUP - B) 
 
 
S.NO HEART RATE SPO2 
 Pre test Post test  Pre test 
1 80 73 90 94 
2 90 80 89 94 
3 95 83 87 93 
4 97 90 89 95 
5 99 91 92 96 
6 89 79 91 95 
7 88 72 89 94 
8 100 93 91 96 
9 97 90 90 95 
10 83 80 90 95 
11 92 87 89 94 
12 90 84 90 93 
13 93 86 87 92 
14 91 84 88 93 
15 89 85 90 95 
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CHAPTER V 
DATA ANALYSIS AND INTERPRETATION 
 
PRE and Post values of Heart rate in Group A and 
Group B 
Table III   INDEPENDENT‘t’ TEST 
 
PRE TEST POST TEST 
 
GROUP A GROUP B GROUP A GROUP B 
MEAN 91.933 91.533  90.466 83.800 
Calculated’t’ 
value 0.193 3.070 
p value and 
Level of 
significance 
p >0.05 and not significant p <0.05 and significant 
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MEAN DIFFERENCE BETWEEN GROUP A AND GROUP B – PRE 
TEST (HEART RATE) 
  
 
 
GRAPH 1 
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MEAN DIFFERENCE BETWEEN GROUP A AND GROUP B – 
POST TEST (HEART RATE) 
 
 
 
GRAPH 2 
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PRE and Post values of Heart rate in Experimental group and 
Control group 
 
 
Table IV   PAIRED‘t’ TEST 
GROUP A GROUP B 
 
PRE TEST POST TEST PRE TEST POST TEST 
 
MEAN 91.933 89.800 91.533 83.800 
Calculated’t’ 
value 2.951 9.245 
p value and 
Level of 
significance 
p <0.05 and significant p <0.05 and significant 
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MEAN DIFFERENCE BETWEEN  PRE AND POST TEST GROUP A  
(HEART RATE) 
 
 
 
GRAPH 3 
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MEAN DIFFERENCE BETWEEN  PRE AND POST TEST GROUP B  
(HEART RATE) 
 
 
 
GRAPH 4 
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PRE and Post values of SPO2 in Group A and Group B 
 
Table V   INDEPENDENT ‘t’ TEST 
PRE TEST POST TEST 
 
GROUP A GROUP B GROUP A GROUP B 
MEAN 89.400 89.466 91.266 94.266 
 
Calculated’t’ 
value 
0.132 7.259 
p value and 
Level of 
significance 
p >0.05 and not significant p <0.05 and significant 
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MEANS DIFFERENCE BETWEEN GROUP A AND GROUP B –PRE 
TEST (SPO2) 
 
 
 
GRAPH 5 
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MEANS DIFFERENCE BETWEEN GROUP A AND GROUP B –
POST  TEST (SPO2) 
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PRE and Post values of SPO2 in Experimental group and 
Control group 
Table 6    PAIRED‘t’ TEST 
GROUP A GROUP B 
 
PRE TEST POST TEST PRE TEST POST TEST 
 
MEAN 89.400 91.266 89.466 94.266 
 
Calculated’t’ 
value 
6.820 24.00 
p value and 
Level of 
significance 
p <0.05 and significant p <0.05 and significant 
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MEAN DIFFERENCE BETWEEN  PRE AND POST TEST GROUP A  
(SPO2) 
 
 
GRAPH 7 
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MEAN DIFFERENCE BETWEEN PRE AND POST TEST 
GROUPB  (SPO2) 
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CHAPTER VI 
 
RESULTS 
 
 
Effectiveness of experimental group and control group was measured by 
comparing pre test and post test values in heart rate and SPO2.  
 
The pre test values of both the groups were analysed using independent‘t’ test. 
For 28 degrees of freedom and 5% level of significance, the table‘t’ value is 2.048 and  
the calculated ‘t’ value is 0.193. As the calculated‘t’ value was lesser than the table‘t’ 
value, there was no significant difference between the pre test values of both groups. 
Hence there was homogeneity between both the groups before the intervention. 
 
The post test values of both the groups were analysed using independent‘t’ test. 
For 28 degrees of freedom and 5% level of significance, the table‘t’ value is 2.048 and  
the calculated ‘t’ value is 3.070 . As the calculated‘t’ value was greater than the table‘t’ 
value, null hypothesis is rejected. Hence there is significant difference between Group A 
and Group B . 
 
The pre test and post test values of heart rate was analysed using paired‘t’ test. 
For 14 degrees of freedom and at 5% level of significance, the table‘t’ value is 2.145 and 
the calculated ‘t’ value was 2.951. As the calculated‘t’ value was greater than the table‘t’ 
value, null hypothesis was rejected. Hence there was significant effect of diaphragmatic 
breathing exercise on heart rate. 
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The pre test and post test values of heart rate were analysed using Paired’t’ test. 
For 14 degrees of freedom and at 5% level of significance, the table‘t’ value is 2.145 and 
the calculated ‘t’ value was 9.245. As the calculated‘t’ value was greater than the table‘t’ 
value, null hypothesis was rejected. Hence there was significant effect of stretching and 
tread mill exercise on heart rate. 
 
The pre test values of both the groups were analysed using independent‘t’ test. 
For 28 degrees of freedom and 5% level of significance, the table‘t’ value is 2.048 and  
the calculated ‘t’ value is 0.132. As the calculated‘t’ value was lesser than the table‘t’ 
value; there was no significant difference between the pre test values of both groups. 
Hence there was homogeneity between both the groups before the intervention. 
 
The post test values of both the groups were analysed using independent‘t’ test. 
For 28 degrees of freedom and 5% level of significance, the table‘t’ value is 2.048 and  
the calculated ‘t’ value is 7.259 . As the calculated‘t’ value was greater than the table‘t’ 
value, null hypothesis is rejected. Hence there is significant difference between Group A 
and Group B. 
 
The pre test and post test values of SPO2 was analysed using Paired’t’ test. For 14 
degrees of freedom and at 5% level of significance, the table‘t’ value is 2.145 and the 
calculated ‘t’ value was 6.820. As the calculated‘t’ value was greater than the table‘t’ 
value, null hypothesis was rejected. Hence there was significant effect of diaphragmatic 
breathing exercise on SPO2. 
 
The pre test and post test values ofSPO2was analysed using Paired’t’ test. For 
14degrees of freedom and at 5% level of significance, the table‘t’ value is 2.145 and the 
calculated ‘t’ value was 24.000. As the calculated‘t’ value was greater than the table‘t’ 
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value, null hypothesis was rejected. Hence there was significant effect of stretching and 
treadmill exercise on Spo2. 
 
The study reveal that there is significant improvement in heart rate and spo2 on 
subject who underwent upper limb and lower limb stretching along with treadmill 
training. 
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CHAPTER VII 
DISCUSSION 
 In COPD subjects basically there is high heart rate and low oxygen saturation.so 
here we are trying to give an effective treatment to improve the heart rate and oxygen 
saturation. In this study, after getting consent,30 subject were taken and randomly 
allocated to 15 in GROUP A and others in GROUP B.Upper limb exercises and 10 
minutes treadmill training along with conventional therapy were administered to 
GROUP B subjects and diaphragmatic breathing exercise and chest mobility exercise 
were suggested to GROUP A subjects as conventional therapy.Pre-test and post-test 
assesment were taken on the basis of two outcome measures. Heart rate and SPO2 were 
measured using the pulsoximeter.Data were statistically analyse by using independent 
and paired t test. 
 Pre test measurement shows homogeneity between the groups.post test 
measurement shows a significant difference between the groups in heart rate and SPO2. 
 In GROUP A, diaphragmatic breathing exercise and chest mobility exercise were 
given, There was a significant difference in heart rate and SPO2.It helped the subjects to 
modify his attitude towards work and thereby reducing his anxiety. It was associated 
with a significant increase in tidal volume and reduction in breathing frequency, leading 
to higher ventilation and O2saturation, with reduction in dead space and ventilatoy 
equivalent forCOPD. Diaphragmatic breathing and chest mobility exercises can also 
improve breathing patternand ventilator efficiency. 
In GROUP B,where upper limb exercise and 10 minutes treadmill training were 
given along with conventional therapy,there was a significant difference in heart rate and 
spo2.These exercises helped in exercise capacity,improves endurance and reduce o2 
consumption at given work load.This intent helped to increase the saturation of o2 and 
decreases the heart rate.The complexity of training induced regulatory changes is well 
illustrated by the effects on heart rate.Normal heart rate response to exercise is mediated 
by a combination of vagal withdrawal and beta adrengic stimulation. 
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CHAPTER VIII 
SUMMARY AND CONCLUSION 
SUMMARY 
This study was conducted to analyse the effectiveness of upper limb exercises 
and 10 minutes treadmill training on COPD patients. It was conducted in two groups. 
GROUP B received upper limb exercises and 10 minutes tread mill training along with 
conventional therapy. While GROUP B received diaphragmatic breathing exercise and 
chest mobility exercise, which lasted for 8 weeks. Heart rate and SPO2 were noted before 
and after training. 
The statistical analyse using paired t test at 5% level of signifance showed that 
there was significant improvement heart rate and SPO2 within the groups. The mean 
showed that GROUP B subjects had more significant improvement than GROUP A.Also 
the statistical analysis using independent t test at 5% level of significance showed that 
there was significant difference in heart rate and SPO2. 
CONCLUSION 
The study proves that upper limb exercises along with 10 minutes tread mill is 
effective in improving the autonomic nervous controlling COPD patients .So this method 
can be used as an effective treatment program in improving the autonomic nervous 
control in COPD patients. This helps the patient to improve the tolerance to exercise and 
other functional activities. So this method is introduced as a safe and most effective 
treatment in management of COPD. 
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CHAPTER IX 
LIMITATIONS AND SUGGESTIONS 
 
LIMITATIONS 
The sample size was small. 
The treatment duration lasted for only 8 weeks. 
Only two outcome measures were taken for the study 
Only male subjects were included in the study. 
The subjects do not have any follow up programme. 
 
SUGGESTIONS 
Studies with larger samples are recommended. 
The further studies can be done with longer duration. 
Further studies can be done with few more outcome measures, such as dyspnoea and 
lung volumes. 
A follow up programme may be useful 
Study should be conducted on both genders to find out whether there is any difference in 
the results between the two groups 
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CHAPTER XII 
APPENDIX I 
INFORMED CONSENT TO PARTICIPATE IN THE RESEARCH 
STUDY 
PATIENT CONSENT FORM 
TITLE 
 Efficacy of Upper Limb Exercise and 10 minutes Treadmill 
Training on Improving Autonomic Nervous control in patients with 
COPD. 
 
INVESTIGATOR: _ _ _ _ _ _ _ _ _ _ _ 
 
PURPOSE OF THE STUDY: 
 I_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  ,have been informed that this study will work 
towards achieving on the functional activities of daily living in post-stroke conditions for 
me and other patients. 
 
PROCEDURE: 
 Each term of the study protocol has been explained to me in detail. I understand  
that during the procedure, I will be receiving the treatment for one time a day. I 
understand that I will have to take this treatment for four weeks. 
 
 I understand that this will be done under investigator, _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
supervision. I am aware also that I have to follow therapist’s instructions as has been told 
to me. 
 
CONFIDENTIALITY: 
             I understand that medical information provided by this study will be confidential. 
If the data are used for publication in the medical literature or for teaching purposes, no 
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names will be used and other literature such as audio or video tapes will be used only 
with permission. 
 
RISK AND DISCOMFORT: 
 I understand that there are no potential risks associated with this procedure, and 
understand that investigator will accompany me during this procedure. There are no 
known hazards associated with this procedure. 
 
REFUSAL OR WITHDRAWAL OF PARTICIPATION: 
 I understand that the decision my participation is wholly voluntary and I may 
refuse participate, may withdraw consent at any time during the study. 
 
 I also understand that the investigator may terminate my participation in the study 
at anytime after researcher has explained me the reasons to do so. 
   
 
I _ _ _ _ _ _ _ _ _ _ _ _ _ _ have explained to …………………………………. the 
purpose of the research, the procedures required and the possible risks and 
benefits, to the best of my ability. 
 
……………………………………                          …………………………… 
 
Investigator                                                  Date 
 
I ………………………………. Confirm that researcher has explained me the 
purpose of the research, the study procedure and the possible risks and benefits 
that I may experience. I have read and I have understood this consent to participate 
as a subject in this research project. 
 
……………………..                                           ………………………… 
 Subject                                                            Date    
………………………..                                        …………………………. 
Signature of  the Witness                                     Date 
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APPENDIX II 
 
CASE ASSESSMENT PROFORMA 
SUBJECTIVE ASSESSMENT 
Name : 
Age  : 
Sex : 
Occupation : 
Address : 
IP/ OP Number : 
Date of evaluation : 
Chief complaints  
 
HISTORY 
Past medical history : 
Present medical history : 
 Onset : 
 Duration : 
Surgical history : 
Drug history : 
Personal history : 
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ASSOCIATED PROBLEMS: 
Vital signs  
 Temperature : 
 Pulse rate : 
 Respiratory rate : 
 Blood pressure : 
 
 
 
 
 
 
 
 
 
 
                                                                            
 
                                                                                                      Physical therapy student 
 
                                                                                                                         Signature 
 
 
 
 
 
 HEART RATE SPO2 
PRE TEST   
POST 
TEST 
  
